Jianbin Li

1.5k total citations
97 papers, 907 citations indexed

About

Jianbin Li is a scholar working on Oncology, Artificial Intelligence and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jianbin Li has authored 97 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 18 papers in Artificial Intelligence and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jianbin Li's work include HER2/EGFR in Cancer Research (14 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer Treatment and Pharmacology (7 papers). Jianbin Li is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer Treatment and Pharmacology (7 papers). Jianbin Li collaborates with scholars based in China, United States and Hong Kong. Jianbin Li's co-authors include Zefei Jiang, Han‐Xiong Li, Zhizhong Liu, Yong Wang, Gary G. Yen, Jinwei Liu, Long Cheng, Cuizhi Geng, Kunchang Li and Xin Yao and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Cancer.

In The Last Decade

Jianbin Li

87 papers receiving 880 citations

Peers

Jianbin Li
Tony Pan United States
R.N.G. Naguib United Kingdom
Jianbin Li
Citations per year, relative to Jianbin Li Jianbin Li (= 1×) peers Shuhao Wang

Countries citing papers authored by Jianbin Li

Since Specialization
Citations

This map shows the geographic impact of Jianbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbin Li more than expected).

Fields of papers citing papers by Jianbin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbin Li. The network helps show where Jianbin Li may publish in the future.

Co-authorship network of co-authors of Jianbin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbin Li. A scholar is included among the top collaborators of Jianbin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbin Li. Jianbin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, Jianwei Zhang, Jianbin Li, et al.. (2025). Nano-single-crystal co-free li-rich Mn-based layered cathode for long-cycling high-energy lithium-ion batteries. Journal of Colloid and Interface Science. 701. 138697–138697.
4.
Li, Jianbin, Shu Wang, Shaohua Zhang, et al.. (2025). Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2. PubMed. 6. 21–21. 1 indexed citations
5.
Cheng, Wei, Jianbin Li, & Jian Yang. (2024). Optimal Timing of Raw-material Acquisition under Fluctuating Prices. SSRN Electronic Journal. 1 indexed citations
7.
Li, Jianbin, et al.. (2023). An Efficient Federated Learning System for Network Intrusion Detection. IEEE Systems Journal. 17(2). 2455–2464. 58 indexed citations
8.
Li, Jinghao, et al.. (2023). Multi-channel Walk Embedding Based Ethereum Phishing Scam Detection Method. 289–295. 5 indexed citations
9.
Zhang, Han, Handing Xia, Mengqiu Fan, et al.. (2023). Observation of Wavelength Tuning in a Mode-Locked Figure-9 Fiber Laser. Photonics. 10(2). 184–184. 8 indexed citations
10.
11.
Wu, Xuan, Yilei Mao, Nong Xu, et al.. (2023). 601P Pembrolizumab in patients of Chinese descent with microsatellite instability-high/mismatch repair deficient advanced solid tumors: KEYNOTE-158. Annals of Oncology. 34. S1707–S1707. 1 indexed citations
12.
13.
Jiang, Zefei, Erwei Song, Cuizhi Geng, et al.. (2022). Chinese society of clinical oncology (CSCO) Breast Cancer Guidelines 2022. PubMed. 3. 13–13. 39 indexed citations
15.
Jin, Liang, Kai Chen, Cui Tan, et al.. (2020). Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer. The Oncologist. 25(8). e1170–e1180. 6 indexed citations
16.
Rui, Ting, et al.. (2020). Visual SLAM in dynamic environments based on object detection. Defence Technology. 17(5). 1712–1721. 38 indexed citations
17.
Zhao, Wei, Li Bian, Tao Wang, et al.. (2020). Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study. Chinese Journal of Cancer Research. 32(3). 361–369. 5 indexed citations
18.
Li, Jianbin, Shusen Wang, Yongsheng Wang, et al.. (2017). Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China. The Oncologist. 22(11). 1333–1338. 35 indexed citations
19.
Li, Jianbin, Zhiqiang Mi, Xiaoping An, et al.. (2012). Random shRNA Library Screen for shRNAs Targeting HIV-1 LTR Related Host Factors with TK Suicide Gene. Zhongguo shengwu gongcheng zazhi. 32(9). 48–54. 1 indexed citations
20.
Jiao, Hongliang, Fangxia Guan, Bo Yang, et al.. (2011). Human amniotic membrane derived-mesenchymal stem cells induce C6 glioma apoptosis in vivo through the Bcl-2/caspase pathways. Molecular Biology Reports. 39(1). 467–473. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026